Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human prourokinase vs rt-PA in acute STEMI (≤85 kg)
CTR20140837Phase 3Active
- Sponsor
- Suzhou Landing Biopharmaceutical
- Start
- Jun 2016
- Modality
- Metabolic Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human prourokinase in myocardial infarction (MI), sponsored by Suzhou Landing Biopharmaceutical. Started Jun 2016; status: active.
02
Drugs
recombinant human prourokinase
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on CTR20140837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140837.